A randomized clinical endpoint study to evaluate the safety and efficacy of clearliv tablets in patients with alcoholic liver disease

Authors
Category Primary study
JournalAsian Journal of Pharmaceutical and Clinical Research
Year 2019
This article has no abstract
Epistemonikos ID: a64d226261561a70c1ad7f63e4d26c16c5784c6e
First added on: Nov 24, 2021